Insights for the Design of Protein Lysine Methyltransferase G9a Inhibitors

References

• Strahl BD , AllisCD. The language of covalent histone modifications. Nature403(6765), 41–45 (2000).
   PubMed Web of Science ®Google Scholar
• Berger SL . The complex language of chromatin regulation during transcription. Nature447(7143), 407–412 (2007).
   PubMed Web of Science ®Google Scholar
• Berger SL , KouzaridesT , ShiekhattarR , ShilatifardA. An operational definition of epigenetics. Genes Dev.23(7), 781–783 (2009).
   PubMed Web of Science ®Google Scholar
• Arents G , BurlingameRW , WangBC , LoveWE , MoudrianakisEN. The nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-handed superhelix. Proc. Natl Acad. Sci. USA88(22), 10148–10152 (1991).
   PubMed Web of Science ®Google Scholar
• Spotswood HT , TurnerBM. An increasingly complex code. J. Clin. Invest.110(5), 577–582 (2002).
   PubMed Web of Science ®Google Scholar
• Allfrey G , FaulknerR , MirskyAE , AllfreyVG , FaulknerR , MirskyAE. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl Acad. Sci. USA51(5), 786–794 (1964).
   PubMed Web of Science ®Google Scholar
• Bannister AJ , KouzaridesT. Regulation of chromatin by histone modifications. Cell Res.21(3), 381–395 (2011).
   PubMed Web of Science ®Google Scholar
• Kouzarides T . Chromatin modifications and their function. Cell128(4), 693–705 (2007).
   PubMed Web of Science ®Google Scholar
• Liu Y , LiuK , QinS , XuC , MinJ. Epigenetic targets and drug discovery: part 1: histone methylation. Pharmacol. Ther.143(3), 275–294 (2014).
   PubMed Web of Science ®Google Scholar
• Copeland RA , SolomonME , RichonVM. Protein methyltransferases as a target class for drug discovery. Nat. Rev. Drug Discov.8(9), 724–732 (2009).
   PubMed Web of Science ®Google Scholar
• Copeland RA . Protein methyltransferase inhibitors as personalized cancer therapeutics. Drug Discov. Today Ther. Strateg.9(2–3), e83–e90 (2012).
   Google Scholar
• Arrowsmith CH , BountraC , FishP V , LeeK , SchapiraM. Epigenetic protein families: a new frontier for drug discovery. Nat. Rev. Drug Discov.11(5), 384–400 (2012).
   PubMed Web of Science ®Google Scholar
• Barski A , CuddapahS , CuiKet al. High-resolution profiling of histone methylations in the human genome. Cell129(4), 823–837 (2007).
   PubMed Web of Science ®Google Scholar
• Jones PA , BaylinSB. The epigenomics of cancer. Cell128(4), 683–692 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson CB , RowellE , SekimataM. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol.9(2), 91–105 (2009).
   PubMed Web of Science ®Google Scholar
• Tsankova N , RenthalW , KumarA , NestlerEJ. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci.8(5), 355–367 (2007).
   PubMed Web of Science ®Google Scholar
• Dunham I , SargentCA , KendallE , CampbellRD. Characterization of the class III region in different MHC haplotypes by pulsed-field gel electrophoresis. Immunogenetics32(3), 175–182 (1990).
   PubMed Web of Science ®Google Scholar
• Rea S , EisenhaberF , O'CarrollDet al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature406(6796), 593–599 (2000).
   PubMed Web of Science ®Google Scholar
• O'Carroll D , ScherthanH , Petersa Het al. Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression. Mol. Cell. Biol.20(24), 9423–9433 (2000).
   PubMed Web of Science ®Google Scholar
• Zhang X , TamaruH , KhanSIet al. Structure of the Neurospora SET domain protein DIM-5, a histone H3 lysine methyltransferase. Cell111(1), 117–127 (2002).
   PubMed Web of Science ®Google Scholar
• Jenuwein T , LaibleG , DornR , ReuterG. SET domain proteins modulate chromatin domains in eu- and heterochromatin. Cell. Mol. Life Sci.54(1), 80–93 (1998).
   PubMed Web of Science ®Google Scholar
• Dillon SC , ZhangX , TrievelRC , ChengX. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol.6(8), 227 (2005).
   PubMed Web of Science ®Google Scholar
• Tachibana M , UedaJ , FukudaMet al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev.19(7), 815–826 (2005).
   PubMed Web of Science ®Google Scholar
• Tachibana M , SugimotoK , FukushimaT , ShinkaiY. SET domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem.276(27), 25309–25317 (2001).
   PubMed Web of Science ®Google Scholar
• Tachibana M , SugimotoK , NozakiMet al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev.16(14), 1779–1791 (2002).
   PubMed Web of Science ®Google Scholar
• Yu Y , SongC , ZhangQet al. Histone H3 lysine 56 methylation regulates DNA replication through its interaction with PCNA. Mol. Cell46(1), 7–17 (2012).
   PubMed Web of Science ®Google Scholar
• Weiss T , HergethS , ZeisslerUet al. Histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D. Epigenetics chromatin3(1), 7 (2010).
   PubMedGoogle Scholar
• Trojer P , ZhangJ , YonezawaMet al. Dynamic histone H1 isotype 4 methylation and demethylation by histone lysine methyltransferase G9a/KMT1C and the jumonji domain-containing JMJD2/KDM4 proteins. J. Biol. Chem.284(13), 8395–8405 (2009).
   PubMed Web of Science ®Google Scholar
• Lan J , LepikhovK , GiehrP , WalterJ. Histone and DNA methylation control by H3 serine 10/threonine 11 phosphorylation in the mouse zygote. Epigenetics Chromatin10(1), 5 (2017).
   PubMedGoogle Scholar
• Chin HG , PradhanM , EstèvePO , PatnaikD , EvansTC , PradhanS. Sequence specificity and role of proximal amino acids of the histone H3 tail on catalysis of murine G9a lysine 9 histone H3 methyltransferase. Biochemistry44(39), 12998–13006 (2005).
   PubMed Web of Science ®Google Scholar
• Rathert P , DhayalanA , MurakamiMet al. Protein lysine methyltransferase G9a acts on non-histone targets. Nat. Chem. Biol.4(6), 344–346 (2008).
   PubMed Web of Science ®Google Scholar
• Sancho M , DianiE , BeatoM , JordanA. Depletion of human histone H1 variants uncovers specific roles in gene expression and cell growth. PLoS Genet.4(10), (2008).
   PubMed Web of Science ®Google Scholar
• Huang J , DorseyJ , ChuikovSet al. G9a and GLP methylate lysine 373 in the tumor suppressor p53. J. Biol. Chem.285(13), 9636–9641 (2010).
   PubMed Web of Science ®Google Scholar
• Ling BMT , BharathyN , ChungT-Ket al. Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc. Natl Acad. Sci. USA109(3), 841–846 (2012).
   PubMed Web of Science ®Google Scholar
• Lee JS , KimY , KimISet al. Negative regulation of hypoxic responses via induced reptin methylation. Mol. Cell39(1), 71–85 (2010).
   PubMed Web of Science ®Google Scholar
• Choi J , JangH , KimHet al. Modulation of lysine methylation in myocyte enhancer factor 2 during skeletal muscle cell differentiation. Nucleic Acids Res.42(1), 224–234 (2014).
   PubMed Web of Science ®Google Scholar
• Nair SS , LiDQ , KumarR. A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes. Mol. Cell49(4), 704–718 (2013).
   PubMed Web of Science ®Google Scholar
• Sampath SC , MarazziI , YapKLet al. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol. Cell27(4), 596–608 (2007).
   PubMed Web of Science ®Google Scholar
• Purcell DJ , JeongKW , BittencourtD , GerkeDS , StallcupMR. A distinct mechanism for coactivator versus corepressor function by histone methyltransferase G9a in transcriptional regulation. J. Biol. Chem.286(49), 41963–41971 (2011).
   PubMed Web of Science ®Google Scholar
• Bittencourt D , WuD-Y , JeongKWet al. G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes. Proc. Natl Acad. Sci. USA109(48), 19673–19678 (2012).
   PubMed Web of Science ®Google Scholar
• Purcell DJ , KhalidO , OuCYet al. Recruitment of coregulator G9a by Runx2 for selective enhancement or suppression of transcription. J. Cell. Biochem.113(7), 2406–2414 (2012).
   PubMed Web of Science ®Google Scholar
• Tamaru H , SelkerEU. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature414(6861), 277–283 (2001).
   PubMed Web of Science ®Google Scholar
• Tachibana M , MatsumuraY , FukudaM , KimuraH , ShinkaiY. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J.27(20), 2681–2690 (2008).
   PubMed Web of Science ®Google Scholar
• Auclair G , BorgelJ , SanzLAet al. EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos. Genome Res.26(2), 192–202 (2016).
   PubMed Web of Science ®Google Scholar
• Feldman N , GersonA , FangJet al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol.8(2), 188–194 (2006).
   PubMed Web of Science ®Google Scholar
• Yamamizu K , FujiharaM , TachibanaMet al. Protein kinase A determines timing of early differentiation through epigenetic regulation with G9a. Cell Stem Cell10(6), 759–770 (2012).
   PubMed Web of Science ®Google Scholar
• Chen X , Skutt-KakariaK , DavisonJet al. G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. Genes Dev.26(22), 2499–2511 (2012).
   PubMed Web of Science ®Google Scholar
• Chang Y , ZhangX , HortonJRet al. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nat. Struct. Mol. Biol.16(3), 312–317 (2009).
   PubMed Web of Science ®Google Scholar
• Ma DK , ChiangC-HJ , PonnusamyK , MingG-L , SongH. G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells. Stem Cells26(8), 2131–2141 (2008).
   PubMed Web of Science ®Google Scholar
• Kubicek S , O’SullivanRJ , AugustEMet al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell25(3), 473–481 (2007).
   PubMed Web of Science ®Google Scholar
• Shi Y , DespontsC , DoJT , HahmHS , SchölerHR , DingS. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell3(5), 568–574 (2008).
   PubMed Web of Science ®Google Scholar
• Ding J , LiT , WangXet al. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metabolism18(6), 896–907 (2013).
   PubMed Web of Science ®Google Scholar
• McGrath J , TrojerP. Targeting histone lysine methylation in cancer. Pharmacol. Ther.150, 1–22 (2015).
   PubMed Web of Science ®Google Scholar
• Esteve P-O , ChinHG , SmallwoodAet al. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev.20(22), 3089–3103 (2006).
   PubMed Web of Science ®Google Scholar
• Oh S-T , KimK-B , ChaeY-C , KangJ-Y , HahnY , SeoS-B. H3K9 histone methyltransferase G9a-mediated transcriptional activation of p21. FEBS Lett.588(5), 685–691 (2014).
   PubMed Web of Science ®Google Scholar
• Ren A , QiuY , CuiH , FuG. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma. Biochem. Biophys. Res. Commun.459(1), 10–17 (2015).
   PubMed Web of Science ®Google Scholar
• Yu H , LinQ , WangYet al. Inhibition of H3K9 methyltransferases G9a/GLP prevents ototoxicity and ongoing hair cell death. Cell Death Dis.4(2), e506 (2013).
   PubMedGoogle Scholar
• Yuan Y , TangAJ , CastorenoABet al. Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells. Cell Death Dis.4(6), e690 (2013).
   PubMedGoogle Scholar
• Shi X , KachirskaiaI , YamaguchiHet al. Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol. Cell27(4), 636–646 (2007).
   PubMed Web of Science ®Google Scholar
• Huang J , Perez-BurgosL , PlacekBJet al. Repression of p53 activity by Smyd2-mediated methylation. Nature444(7119), 629–632 (2006).
   PubMed Web of Science ®Google Scholar
• Chuikov S , KurashJK , WilsonJRet al. Regulation of p53 activity through lysine methylation. Nature432(7015), 353–360 (2004).
   PubMed Web of Science ®Google Scholar
• Huang J , DorseyJ , ChuikovSet al. G9a and GLP methylate lysine 373 in the tumor suppressor p53. J. Biol. Chem.285(13), 9636–9641 (2010).
   PubMed Web of Science ®Google Scholar
• Levine B , KroemerG. Autophagy in the pathogenesis of disease. Cell132(1), 27–42 (2008).
   PubMed Web of Science ®Google Scholar
• Mizushima N , LevineB , CuervoAM , KlionskyDJ. Autophagy fights disease through cellular self-digestion. Nature451(7182), 1069–1075 (2008).
   PubMed Web of Science ®Google Scholar
• de Narvajas AA , GomezTS , ZhangJS et al. Epigenetic regulation of autophagy by the methyltransferase G9a. Molecular and Cell. Biol.33(20), 3983–3993 (2013).
   PubMed Web of Science ®Google Scholar
• Scheer S , ZaphC. The lysine methyltransferase G9a in immune cell differentiation and function. Front. Immunol.8, 429 (2017).
   PubMed Web of Science ®Google Scholar
• Katoh K , YamazakiR , OnishiA , SanukiR , FurukawaT. G9a histone methyltransferase activity in retinal progenitors is essential for proper differentiation and survival of mouse retinal cells. J. Neurosci.32(49), 17658–17670 (2012).
   PubMed Web of Science ®Google Scholar
• Lyons DB , MagklaraA , GohTet al. Heterochromatin-mediated gene silencing facilitates the diversification of olfactory neurons. Cell Rep.9(3), 884–892 (2014).
   PubMed Web of Science ®Google Scholar
• Ebbers L , RungeK , NothwangHG. Differential patterns of histone methylase EHMT2 and its catalyzed histone modifications H3K9me1 and H3K9me2 during maturation of central auditory system. Cell Tissue Res.365(2), 247– 264 (2016).
   PubMed Web of Science ®Google Scholar
• Harris JA , HardieNA , Bermingham-McDonoghO , RubelEW. Gene expression differences over a critical period of afferent-dependent neuron survival in the mouse auditory brainstem. J. Comp. Neurol.493(3), 460–474 (2005).
   PubMed Web of Science ®Google Scholar
• Casciello F , WindlochK , GannonF , LeeJS. Functional role of G9a histone methyltransferase in cancer. Front. Immunol.6487 (2015).
   PubMed Web of Science ®Google Scholar
• Laumet G , GarrigaJ , ChenS-Ret al. G9a is essential for epigenetic silencing of K+ channel genes in acute-to-chronic pain transition. Nat. Neurosci.18(12), 1746–1755 (2015).
   PubMed Web of Science ®Google Scholar
• Benevento M , vande Molengraft M , van WestenR , van BokhovenH , KasriNN. The role of chromatin repressive marks in cognition and disease: A focus on the repressive complex GLP/G9a. Neurobiol. Learn. Mem.124, 88–96 (2015).
   PubMed Web of Science ®Google Scholar
• Gupta S , KimSY , ArtisSet al. Histone methylation regulates memory formation. J. Neurosci.30(10), 3589–3599 (2010).
   PubMed Web of Science ®Google Scholar
• Gupta-Agarwal S , FranklinA V , DeramusTet al. G9a/GLP histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation. J. Neurosci.32(16), 5440–5453 (2012).
   PubMed Web of Science ®Google Scholar
• Schaefer A , SampathSC , IntratorAet al. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron64(5), 678–691 (2009).
   PubMed Web of Science ®Google Scholar
• Heller EA , CatesHM , PeñaCJet al. Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors. Nat. Neurosci.17(12), 1720–1727 (2014).
   PubMed Web of Science ®Google Scholar
• Maze I , CovingtonHE , DietzDMet al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science327(5962), 213–216 (2010).
   PubMed Web of Science ®Google Scholar
• Rothman RB . High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development. Life Sci.46(20), PL17–PL21 (1990).
   PubMed Web of Science ®Google Scholar
• Peña CJ , BagotRC , LabontéB , NestlerEJ. Epigenetic signaling in psychiatric disorders. J. Mol. Biol.426(20), 3389–3412 (2014).
   PubMed Web of Science ®Google Scholar
• Walker MP , LaFerlaFM , OddoSS , BrewerGJ. Reversible epigenetic histone modifications and BDNF expression in neurons with aging and from a mouse model of Alzheimer’s disease. AGE35(3), 519–531 (2013).
   PubMed Web of Science ®Google Scholar
• Gardian G , BrowneSE , ChoiD-Ket al. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington’s disease. J. Biol. Chem.280(1), 556–563 (2005).
   PubMed Web of Science ®Google Scholar
• Ferrante RJ , RyuH , KubilusJKet al. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington’s disease. J. Neurosci.24(46), 10335–10342 (2004).
   PubMed Web of Science ®Google Scholar
• Li M , LiuC , YangLet al. G9a-mediated histone methylation regulates cadmium-induced male fertility damage in pubertal mice. Toxicol. Lett.252, 11–21 (2016).
   PubMed Web of Science ®Google Scholar
• Chen MW , HuaKT , KaoHJet al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res.70(20), 7830–7840 (2010).
   PubMed Web of Science ®Google Scholar
• Cho H-S , KellyJD , HayamiSet al. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia13(8), 676–684 (2011).
   PubMed Web of Science ®Google Scholar
• Qin J , LiQ , ZengZet al. Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma. Oncol. Lett.15(6), 9757–9765 (2018).
   PubMed Web of Science ®Google Scholar
• Sandoval J , EstellerM. Cancer epigenomics: beyond genomics. Curr. Opin. Genet. Dev.22(1), 50–55 (2012).
   PubMed Web of Science ®Google Scholar
• Greer EL , ShiY. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet.13(5), 343–57 (2012).
   PubMed Web of Science ®Google Scholar
• Gao J , AksoyBA , DogrusozUet al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal.6(269), pl1 (2013).
   PubMed Web of Science ®Google Scholar
• Hua K-TK , WangM-Y , ChenMM-Wet al. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis. Mol. Cancer13(1), 189 (2014).
   PubMedGoogle Scholar
• Kang J , ShinS-H , YoonHet al. FIH Is an oxygen sensor in ovarian cancer for G9a/GLP-driven epigenetic regulation of metastasis-related genes. Cancer Res.78(5), 1184–1199 (2018).
   PubMed Web of Science ®Google Scholar
• Lee JS , KimY , BhinJet al. Hypoxia-induced methylation of a pontin chromatin remodeling factor. Proc. Natl Acad. Sci. USA108(33), 13510–13515 (2011).
   PubMed Web of Science ®Google Scholar
• Wozniak RJ , KlimeckiWT , LauSS , FeinsteinY , FutscherBW. 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene26(1), 77–90 (2007).
   PubMed Web of Science ®Google Scholar
• Zhong X , ChenX , GuanXet al. Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis. Histopathology66(2), 192–200 (2015).
   PubMed Web of Science ®Google Scholar
• Chen W-L , SunH-P , LiD-D , WangZ-H , YouQ-D , GuoX-K. G9a: an appealing antineoplastic target. Curr. Cancer Drug Targets17(6), 555–568 (2017).
   PubMed Web of Science ®Google Scholar
• Rhodes DR , YuJ , ShankerKet al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia6(1), 1–6 (2004).
   PubMed Web of Science ®Google Scholar
• Lin X , HuangY , ZouY , ChenX , MaX. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma. Oncol. Rep.35(5), 3041–3049 (2016).
   PubMed Web of Science ®Google Scholar
• Lee SH , KimJ , KimWH , LeeYM. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene28(2), 184–194 (2009).
   PubMed Web of Science ®Google Scholar
• Cho HS , KellyJD , HayamiSet al. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia13(8), 676–684 (2011).
   PubMed Web of Science ®Google Scholar
• Cui J , SunW , HaoXet al. EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells. Cancer Cell Int.15(1), 4 (2015).
   PubMedGoogle Scholar
• Li F , ZengJ , GaoYet al. G9a inhibition induces autophagic cell death via AMPK/mTOR pathway in bladder transitional cell carcinoma. PLoS ONE10(9), e0138390 (2015).
   PubMed Web of Science ®Google Scholar
• Pappano WN , GuoJ , HeYet al. The histone methyltransferase inhibitor A-366 uncovers a role for G9a/GLP in the epigenetics of leukemia. PLoS ONE10(7), e0131716 (2015).
   PubMed Web of Science ®Google Scholar
• Lehnertz B , PabstC , SuLet al. The methyltransferase G9a regulates HoxA9-dependent transcription in AML. Genes Dev.28(4), 317–327 (2014).
   PubMed Web of Science ®Google Scholar
• Penas C , NavarroX. Epigenetic modifications associated to neuroinflammation and neuropathic pain after neural trauma. Front. Cell. Neurosci.12, 158 (2018).
   PubMed Web of Science ®Google Scholar
• Deimling SJ , OlsenJB , TropepeV. The expanding role of the Ehmt2/G9a complex in neurodevelopment. Neurogenesis4(1), e1316888 (2017).
   Google Scholar
• Brown SE , CampbellRD , SandersonCM. Novel NG36/G9a gene products encoded within the human and mouse MHC class III regions. Mamm. Genome12(12), 916–924 (2001).
   PubMed Web of Science ®Google Scholar
• Fiszbein A , GionoLE , QuaglinoAet al. Alternative splicing of G9a regulates neuronal differentiation. Cell Rep.2797–2808 (2016).
   PubMed Web of Science ®Google Scholar
• Kleefstra T , KramerJM , NevelingKet al. Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. Am. J. Hum. Genet.91(1), 73–82 (2012).
   PubMed Web of Science ®Google Scholar
• Pasillas MP , ShahM , KampsMP. NSD1 PHD domains bind methylated H3K4 and H3K9 using interactions disrupted by point mutations in human Sotos syndrome. Hum. Mutat.32(3), 292–8 (2011).
   PubMed Web of Science ®Google Scholar
• Maas NMC , Van BuggenhoutG , HannesFet al. Genotype-phenotype correlation in 21 patients with Wolf–Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH). J. Med. Genet.45(2), 71–80 (2008).
   PubMed Web of Science ®Google Scholar
• Miyake N , MizunoS , OkamotoNet al. KDM6A point mutations cause Kabuki syndrome. Hum. Mutat.34(1), 108–110 (2013).
   PubMed Web of Science ®Google Scholar
• Gibson WT , HoodRL , ZhanSHet al. Mutations in EZH2 cause Weaver syndrome. Am. J. Hum. Genet.90(1), 110–118 (2012).
   PubMed Web of Science ®Google Scholar
• Iwase S , LanF , BaylissPet al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell128(6), 1077–1088 (2007).
   PubMed Web of Science ®Google Scholar
• Armanet N , MetayC , BrissetSet al. Double Xp11.22 deletion including SHROOM4 and CLCN5 associated with severe psychomotor retardation and Dent disease. Mol. Cytogenet.8, 8 (2015).
   PubMed Web of Science ®Google Scholar
• Barco A . Neuroepigenetic disorders: progress, promises and challenges. Neuropharmacology80, 1–2 (2014).
   PubMed Web of Science ®Google Scholar
• Kleefstra T , SchenckA , KramerJM , van BokhovenH. The genetics of cognitive epigenetics. Neuropharmacology80, 83–94 (2014).
   PubMed Web of Science ®Google Scholar
• Bagot RC , LabontéB , PeñaCJ , NestlerEJ. Epigenetic signaling in psychiatric disorders: stress and depression. Dialogues Clin. Neurosci.16(3), 281–295 (2014).
   PubMed Web of Science ®Google Scholar
• Portela A , EstellerM. Epigenetic modifications and human disease. Nat. Biotechnol.28(10), 1057–1068 (2010).
   PubMed Web of Science ®Google Scholar
• Traynor BJ , RentonAE , JCLet al. Exploring the epigenetics of Alzheimer disease. JAMA Neurol.72(1), 8 (2015).
   PubMed Web of Science ®Google Scholar
• Gräff J , ReiD , GuanJ-Set al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature483(7388), 222–226 (2012).
   PubMed Web of Science ®Google Scholar
• Wood JG , HillenmeyerS , LawrenceCet al. Chromatin remodeling in the aging genome of Drosophila. Aging Cell9(6), 971–978 (2010).
   PubMed Web of Science ®Google Scholar
• Ryu H , LeeJ , HagertySWet al. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington’s disease. Proc. Natl Acad. Sci. USA103(50), 19176–19181 (2006).
   PubMed Web of Science ®Google Scholar
• Shankar SR , BahirvaniAG , RaoVK , BharathyN , OwJR , TanejaR. G9a, a multipotent regulator of gene expression. Epigenetics8(1), 16–22 (2013).
   PubMed Web of Science ®Google Scholar
• Wu H , MinJ , LuninV Vet al. Structural biology of human H3K9 methyltransferases. PLoS ONE5(1), e8570 (2010).
   PubMed Web of Science ®Google Scholar
• Liu F , ChenX , Allali-HassaniAet al. Protein lysine methyltransferase g9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines. J. Med. Chem.53(15), 5844–5857 (2010).
   PubMed Web of Science ®Google Scholar
• Liu F , ChenX , Allali-HassaniAet al. Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J. Med. Chem.52(24), 7950–7953 (2009).
   PubMed Web of Science ®Google Scholar
• Liu F , Barsyte-LovejoyD. Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines. J. Med. Chem.54(17), 6139–6150 (2011).
   PubMed Web of Science ®Google Scholar
• Liu F , Barsyte-LovejoyD , LiFet al. Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP. J. Med. Chem.56(21), 8931–8942 (2013).
   PubMed Web of Science ®Google Scholar
• Chang Y , GaneshT , HortonJRet al. Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases. J. Mol. Biol.400(1), 1–7 (2010).
   PubMed Web of Science ®Google Scholar
• Xiong Y , LiF , BabaultNet al. Discovery of potent and selective inhibitors for G9a-like protein (GLP) lysine methyltransferase. J. Med. Chem.60(5), 1876–1891 (2017).
   PubMed Web of Science ®Google Scholar
• Bárcena-Varela M , CarusoS , LlerenaSet al. Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma. Hepatology69(2), 587–603 (2018).
   Web of Science ®Google Scholar
• Rotili D , TarantinoD , MarroccoBet al. Properly substituted analogues of BIX-01294 lose inhibition of G9a histone methyltransferase and gain selective anti-DNA methyltransferase 3A activity. PLoS ONE9(5), e96941 (2014).
   PubMed Web of Science ®Google Scholar
• Rabal O , José-EnérizES , AgirreXet al. Discovery of reversible dna methyltransferase and lysine methyltransferase G9a Inhibitors with antitumoral in vivo efficacy. J. Med. Chem.61(15), 6518–6545 (2018).
   PubMed Web of Science ®Google Scholar
• Srimongkolpithak N , SundriyalS , LiF , VedadiM , FuchterMJ. Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors. Med. Chem. Commun.5(12), 1821–1828 (2014).
   Google Scholar
• José-Enériz ES , AgirreX , RabalOet al. Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies. Nat. Commun.8, 15424 (2017).
   PubMed Web of Science ®Google Scholar
• Sweis RF , PliushchevM , BrownPJet al. Discovery and development of potent and selective inhibitors of histone methyltransferase G9a. ACS Med. Chem. Lett.5(2), 205–209 (2014).
   PubMed Web of Science ®Google Scholar
• Chen WL , WangZH , FengTTet al. Discovery, design and synthesis of 6H-anthra[1,9-cd]isoxazol-6-one scaffold as G9a inhibitor through a combination of shape-based virtual screening and structure-based molecular modification. Bioorg. Med. Chem.24(22), 6102–6108 (2016).
   PubMed Web of Science ®Google Scholar
• M RCC , HsiehH-P , CoumarMS. Delineating the active site architecture of G9a lysine methyltransferase through substrate and inhibitor binding mode analysis: a molecular dynamics study. J. Biomol. Styruct. Dyn.37(10), 2581 –2592 (2018).
   Google Scholar
• Rowbotham SP , LiF , DostAFMet al. H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression. Nat. Commun.9(1), 4559 (2018).
   PubMedGoogle Scholar